CPI issues safety alert for Ventak PRx AICD.
This article was originally published in The Gray Sheet
Executive SummaryCPI VENTAK PRx SAFETY ALERT was prompted by 24 reports that the automatic implantable cardioverter defibrillator can unintentionally be turned on or off when physicians evaluate the device using a specialized magnetic product. Sales reps for CPI hand-delivered copies of the April 18 safety alert to physicians, the firm said.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.